This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
With Incyte's bread-and-butter Jakafi approaches a 2028 patent cliff, its topica...
Novartis opened the doors to a €40 million ($41.2 million) viral vector facility...
Merck KGaA is said to be in advanced talks to acquire cancer and are disease spe...
Shares of Axsome Therapeutics jumped by more than 20% after the company resolved...
CEO Hervé Affagard discusses MaaT Pharma's new approach to microbiome-driven th...
Experts from Wilco Source and CitiusTech discuss how AWS and Salesforce’s indust...
Andrea Bortolato of $5.6 billion startup SandboxAQ on the opportunity to transfo...
Ramita Tandon, Chief Biopharma Services Officer at Walgreens on the company’s ef...
In this tracker, Fierce Pharma is recording the regulatory progress of in-market...
With another trial win, Bristol Myers Squibb is touting Breyanzi as the CD19-dir...
Neurocrine's stock price took a tumble Friday after the company revealed its 202...
Ten months after Pfizer scored approval in Europe for Emblaveo to treat complica...
Learn about a treatment option with TAGRISSO® (osimertinib).
Fierce Pharma sits down with healthcare executives at Fierce JPM Week 2025. Indu...
Patient relationships are the linchpin of commercial success. Learn how AI, data...
After re-adding Blenrep to its portfolio, GSK now expects sales to reach more th...
Amar Urhekar has reset Avalere Health’s mission. Weeks after naming Urhekar as C...
In this tracker, Fierce Pharma is recording the regulatory progress of in-market...
After recent launches of biosimilar versions of Eylea and Stelara, Amgen project...
As Moderna maps out a more cautious future amid lower-than-expected sales of its...
The CDC Foundation has added muscle to its “Live to the Beat” campaign, enlistin...
AbbVie’s Skyrizi was responsible for the highest TV advertising outlay in pharma...
The company is in talks with individual regulatory authorities after its decisio...
With sales of Novo Nordisk’s obesity blockbuster Wegovy more than doubling in 20...